Chloroquine treatments for Covid-19 patients

Chloroquine treatments for Covid-19 patients - The mayor of Nice, Christian Estrosi, has announced today on Twitter that chloroquine treatments would be authorized at the CHU de Nice for patients with Covid-19.

This antimalarial drug is presented as the miracle remedy, since the tests of Professor Didier Raoult, at the IHU Mediterranean, in Marseille, who presented the first results of the clinical test carried out on 24 patients affected by the coronavirus.

According to the scientist, "those who have not received Plaquenil [a drug based on hydroxychloroquine] are still 90% carriers of the virus after six days, while 25% are positive for those who have received treatment ".

Thursday, the mayor, himself infected by the virus, said in Nice-Matin that he was taking care of himself with his "protocol", under the advice of "specialists from the Nice University Hospital".

Les Echos revealed this Saturday that the protocol will be included with those who make up the "Discovery" trial, a large study led by Inserm on nearly 3,200 European patients.

This trial, which starts this week, will be conducted in a handful of French teaching hospitals and then expanded to several dozen centers.

The patients will be divided into five groups. A placebo group, one to test the effectiveness of an anti-HIV (Kaletra), another which will combine it with interferon beta to modulate the immune response, another to check the effect of an antiviral developed against the Ebola virus (Remdesivir). And a fifth therefore for chloroquine.

This Saturday evening, the Minister of Health, Olivier Véran explained that he wanted to wait before recommending this well-known treatment.